FDA Adverse Event
Malfunction
Summary report: N
TELIGEN
MDR report key: 1860504
·
Received October 7, 2010
Report
- Report Number
- 2124215-2010-14955
- Event Type
- Malfunction
- Date Received
- October 7, 2010
- Date of Event
- January 11, 2010
- Report Date
- July 23, 2010
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
Additional Manufacturer Narrative · 1
AS OF TODAY, THE DEVICE REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS DEVICE HAD A RAPIDLY CONDUCTING ATRIAL FIBRILLATION WHICH RESULTED IN INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) TO BE DELIVERED. THE ATP ACCELERATED THE RHYTHM FOR WHICH INAPPROPRIATE SHOCKS WERE DELIVERED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E102 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | 7000| 6947| E102| 0184 |